Want to see HK:6990 full AI Analyst Report?

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (6990) Financial Statements

2 Followers

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Financial Overview

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H's market cap is currently HK$81.62B. The company's EPS TTM is HK$-1.8; its P/E ratio is -234.83; Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H is scheduled to report earnings on August 17, 2026, and the estimated EPS forecast is HK$0.46. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 2.06B	¥ 1.93B	¥ 1.54B	¥ 803.93M	¥ 31.79M
Gross Profit	¥ 1.48B	¥ 1.27B	¥ 759.18M	¥ 527.11M	¥ -10.93M
Operating Income	¥ -466.19M	¥ -211.40M	¥ -452.61M	¥ -393.93M	¥ -798.79M
EBITDA	¥ -249.23M	¥ -47.36M	¥ -308.31M	¥ -351.19M	¥ -776.25M
Net Income	¥ -381.97M	¥ -266.77M	¥ -574.13M	¥ -616.10M	¥ -875.26M
Balance Sheet
Cash & Short-Term Investments	¥ 4.56B	¥ 3.08B	¥ 2.53B	¥ 117.54M	¥ 100.31M
Total Assets	¥ 5.99B	¥ 4.27B	¥ 3.51B	¥ 993.14M	¥ 996.97M
Total Debt	¥ 88.44M	¥ 126.75M	¥ 59.92M	¥ 3.01B	¥ 2.93B
Net Debt	¥ -3.24B	¥ -1.22B	¥ -1.51B	¥ 2.90B	¥ 2.83B
Total Liabilities	¥ 1.12B	¥ 959.34M	¥ 1.18B	¥ 4.22B	¥ 4.24B
Stockholders' Equity	¥ 4.87B	¥ 3.31B	¥ 2.33B	¥ -3.21B	¥ -3.24B
Cash Flow
Free Cash Flow	¥ -306.55M	¥ -510.89M	¥ -22.69M	¥ -309.84M	¥ -609.73M
Operating Cash Flow	¥ -180.30M	¥ -429.77M	¥ 59.56M	¥ -270.85M	¥ -517.18M
Investing Cash Flow	¥ 411.01M	¥ -822.00M	¥ -1.03B	¥ -32.15M	¥ -92.84M
Financing Cash Flow	¥ 1.73B	¥ 1.04B	¥ 2.38B	¥ 313.45M	¥ 675.92M

Currency in CNY

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Earnings and Revenue History

Income Statement >

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Debt to Assets

Balance Sheet >

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Cash Flow

Cash Flow >

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Forecast EPS vs Actual EPS

Earnings >